Thank you very much for the submission of your research manuscript to our editorial office and for your patience while we were waiting to hear back from the referees. We have just now received the full set of reviews on your manuscript.
Thank you very much for the submission of your research manuscript to our editorial office and for your patience while we were waiting to hear back from the referees. We have just now received the full set of reviews on your manuscript.
As the detailed reports are pasted below I would prefer not to repeat the details of them here. What becomes clear is that while all referees in principle agree on the interest of the study, they also point out instances in which they feel the data needs to be strengthened and they all provide feedback and suggestions on how to achieve this. For example, both referees 2 and 3 state that the contributions of TAZ and TEAD should be analyzed. In general, all reviewers point out instances in which additional controls, clarifications or details on experimental procedures should be provided and overstatements should be toned down. We would not insist on the request of referee 2 to provide further mechanistic insights into the function of Yap1 during differentiation, but you are, of course, welcome to add any data in this directions if you already have them at hand. The same goes for the request of this reviewer to provide a more detailed analysis of the different cell types that arise from the stem cells, but you should tone down the conclusions about the trophoblast/trophectoderm differentiation, as suggested by referee 1.
Given the potential interest of your findings, I would like to give you the opportunity to revise your manuscript, with the understanding that the main concerns of the referees as listed above and in their reports should be addressed. Specific comments. 1) In the way the MS is written, the authors are mainly centering their interpretations around the role of YAP in the mouse embryo. This is a bit old-fashioned, as ESC biology is now considered a field on its own; and, after all, ESCs are cell lines, with their own peculiarities, that only in part or only under specific conditions recapitulate what is going on in their tissue of origin, the ICM of the blastocyst. Moreover the role of YAP in the early embryogenesis (or those of YAP + TAZ), are poorly investigated and far to be clear. The authors should thus avoid overinterpretations.
To start, some statements from the abstract should be removed: "whereas it is sequestered and inactive in the cytoplasm of the inner cell mass (ICM)" this is an overstatement; I am not sure this is functionally proven.
"suggesting a functional discrepancy of Yap1 between in vivo and in vitro settings"; "which recapitulates Yap1 functions in early embryogenesis."
The ES cell field is full of these discrepancies with the blastocyst. This is not the point of this MS, and it would not be a problem.
There is an excessive emphasis on the supposed role of YAP in the trophoblast layer. Actually, YAP inactivation upregulates other differentiation markers, such as mesoderm and endoderm markers. Cdx2 is certainly a trophoblast marker but together with GATA6 it may well indicate endoderm regionalization/patterning. Again, please note that what matters here is YAP being required for differentiation not the fact that this recapitulates or not a corresponding role of YAP in the mouse gastrula, where, in fact, the role of YAP or YAP/TAZ is largely unknown as far as I can tell.
In essence, the author should stick to their data and tone down any blastocyst-centered interpretation of their results.
2) Strange enough, the authors are citing every bit literature (see below my comment on their Ref34, for example), but not a paper that is in fact consistent (not to say quite overlapping) with their own claim. Azzolin et al., in Cell 2014, figure 6, showed that double inactivation of YAP/TAZ has no effect of mouse ESC self-renewal (in line with what shown in this MS), at least in 2-inhibitors (2i) medium (Mek-i+GSK3-i). They also show that, in 1i medium (Mek-i alone), which is in fact a differentiation medium, loss of YAP and TAZ sustains pluripotency (again consistently with the claim of this MS). It appears to me that this 2014 Cell paper was centered on the role of YAP as Wnt inhibitor and did not emphasize this point sufficiently; moreover, Azzolen never showed what was actually going on with those cells nor what differentiation endogenous YAP was eventually promoting. In any case, the present MS does represent sufficient novelty and significantly extend over the Azzolen Cell paper.
In the present MS, the authors must find space (cutting short intro and other embryo-speculations) to discuss comprehensively the state of the art of YAP and mESCs, trying to help the reader in making sense of other reports, some consistent and other inconsistent. In sum: a) they should discuss Azzolin et al., explain what is the overlap with the present MS and to what extend the new data extend those findings.
b) It is also puzzling to understand why Lian et al got remarkably opposite results. It should not be sufficient to state: "it is inconsistent". If one looks carefully at the Lian data, it appears only 1 out of 2 siRNAs (shRNA2, fig2) was really effective in their hands. In this MS at least there is YAP genetic inactivation and consistent YAP KD. Moreover, Lian et al used one ES cell type, the D3 ESC lines; here authors used the established J1 line for YAP knockout. Is there a cell line bias? What cells were used for shRNA KD? Are the KD or KO results similar to J1 when carried out in CJ7, E14? c) There is another paper that the authors should try to mention and discuss if space allows it. Beyer et al., Cell reports 2013, suggested that YAP and TAZ operate as inhibitors of mesendoderm gene expression, at least in human ESCs, suggesting differences between human and mouse ESCs.
3) The MS is not very easy to read and in some part almost impossible to follow: -dES, might be switched to differentiating-differentiated-ESCs -Periods like these should be entirely rewritten for the benefit of the general reader: We also investigated the activity of previously defined functional modules in ES cells (Core and PRC) [26] . Previously, it has been shown that Core module activity is decreased while PRC module activity is increased upon differentiation of ES cells. While dES showed the expected Core and PRC module activities, ES cells with KD or KO of Yap1 showed reversed module activities compared to those of dES cells (Fig 2I) .
Although the down-regulation of Pou5f1 and Nanog were not significantly affected, we found that some pluripotency factors, such as Sox2 and Esrrb were not down-regulated normally during differentiation of Yap1-depleted cells As shown in Figure 3B , DEGs in Yap1-KD cells compared to the control ES cells under differentiation condition confirmed that the genes were not properly up or down-regulated upon differentiation (Table EV3) . We further analyzed the activity of the Core and PRC modules, and confirmed that upon differentiation, the Core module activity was relatively higher while PRC module activity was lower in Yap1-KD cells than wild-type ES cells (Fig 3C) , indicating that KD of Yap1 delayed or impaired proper differentiation of ES cells. Figure 4 . this whole figure is quite diluting the message and provides just correlative data. It is overall preliminary, requiring more experiments to complete the message they are trying to convey. Changing cell density, in turn correlated with changes in Yap1 localization, and then seeing some effects are three and not necessarily interconnected events; but there is no YAP functional link to demonstrate causality. Basically: as it is figure 4 might be deleted without any damage as the MS is on YAP (irrespectively of its regulation) and mESC differentiation and self renewal.
4)
Other suggested/required changes: Figure S1F GAPDH strip has severe problems, at least on my pdf.
11) It is imperative for all their cell line to show the effective knockout of YAP: by sequencing of the locus and western blot. 12) Fig1H is very hard to understand; and not even explained.
13) The following paragraph of the Conclusion on other reports supporting their own results, is incorrect (and a bit unfair) and should be deleted: "This result is consistent with the role of Yap1 in human pluripotent stem cells where Yap1 does not affect the regulation of Pou5f1 or the generation of induced pluripotent stem cells [34, 35] " Ref34 is really on something else. It is on an Rnai screen and simply show YAP siRNAs as negative control, but by no mean this is meaningful (those ref34 oligos were not validated; for Ref34 YAP siRNAs are simply equivalent to GFP siRNAs or unrelated siRNA). By no mean this is a direct study of YAP. Ref35 deals with reprogramming of human fibroblast to iPSCs; little is known, but this is a process perhaps only partially related to the preservation of self-renewal and differentiation of established mES cell lines here investigated.
Referee #2:
In this manuscript Chung et al. explore the roles of Yap1 in mouse ESC differentiation. Based on their observations the authors argue that Yap1 is not required for maintaining ESC pluripotency, but rather is required for proper differentiation of these cells. They show that ESCs depleted of Yap1 show no changes in markers of pluripotency, whereas overexpression of Yap1 induces the expression of genes associated with differentiation. The authors also reason that changes in cell fate markers that result from alterations in cell density, or disruption of cell adhesion, occur as a results of induced nuclear Yap1 activity. Given that Yap1 been described as an ESC regulator, understanding what Yap1 is doing in these cells is of clear importance. This manuscript attempts to study the roles of Yap in ESCs, and while some interesting descriptive observations are made, no detailed insight is gained into Yap function. Additionally, several of the conclusions seem to be based on improperly controlled experiments (based on the presented methods). Therefore, in my opinion much more insight into the role of Yap in ESC fate specification is required before this manuscript can be considered for publication. Moreover, there are several issues that need to be addressed, some of which are outlined below: -The manuscript fails to address or take into account several prior studies that address the roles of Yap1 in ESCs. Most importantly, prior work has shown that Yap1 functions redundantly with Taz in mouse pre-implantation development and in human ES cells. Therefore, depletion of Yap1 in mouse ESCs may not be sufficient to observe any clear phenotypes. The study would benefit from additional analyses of Taz and Yap1/Taz depletion in ESCs.
-No details are given for how the experiments were performed in Figure 2 . The authors state that Yap1 is not required for the self-renewal of ES cells, but do not provide details regarding how the experiments being performed, how many passages were analyzed, or even at when the pluripotency markers were analyzed with respect to depletion.
-The authors argue that loss of Yap1 or overexpression of Yap1 affects the differentiation of ESCs, but no details are given into the specification of these cells. Rather, very broad statements and conclusion are made. A detailed analysis of the various cell fates that may be affected should be performed. Also, given that Yap1 is known to crosstalk with other signals in the context of ESCs (e.g. crosstalk with Lif, Wnt, BMP, TGF-beta, and Notch signaling) any analysis of cell fate should carefully consider these other signals, and if necessary, various culture and differentiation methods should be tested before drawing conclusions.
-Based on the data presented, ESCs appear to have significant changes in gene expression compared to the controls following the loss of Yap1. While this profile is more similar to ESCs than of differentiated EBs, these gene expression changes may be insightful into the roles of Yap1 in ESCs. Do the gene expression changes provide any clues into what Yap1 is doing in cell fate specification? Some analysis of this data, beyond simple correlation, should be included and discussed.
-The details for how Yap1 localization and activity was measured and compared in undifferentiated and differentiating ESCs is unclear. From the methods section it appears that the differentiating ESCs were continually being passaged during the analysis of Yap1, whereas the undifferentiated were not, and therefore dissociation of the cells may be the primary reason for observing increased nuclear Yap1 activity under these conditions. A more clear description of these experiments is required, and if culturing conditions were different, then conclusions with regard to Yap1 activity cannot be drawn from these experiments.
-How was Yap1 overexpression achieved? No details are given. For example, were these lines generated with viral transduction? Are they stably selected? Is the expression constitutive? Were the control cells generated in parallel, and similarly selected? These variables could have a huge influence on the cellular state and must be properly controlled. Additionally, the text states that overexpressed Yap1 mainly resides in the nucleus, but this does not appear to be different that the endogenous Yap shown in the control in Figure 3D . Rather, Yap just appears to be at higher levels.
-Based on the images in 1F, 1G and 3D and -it appears that Yap1 in abundantly localized in the nucleus of undifferentiated ES cells. The one field showing a possible increase in nuclear Yap1 levels in differentiated ES cells is unconvincing on its own -and all the conclusions regarding Yap1 localization would greatly benefit from quantitation and biochemical nuclear/cytoplasmic fractionation examined by immunoblotting.
-A control for Yap1 IF signal should be included in the study, particularly given that the authors have in hand a Yap1 deleted cell line.
-Differences in Yap1 localization in Figure 4A are not clear. To me, nuclear Yap1 levels look similar between the two conditions. Better images and quantitation would help make this conclusion more convincing.
-All the experiments related to cell density or E-cadherin depletion are vastly overstated, as the authors do not provide any evidence that the effects following changes in density or the loss of Ecadherin are mediated by Yap1. To draw any meaningful conclusions, the authors should perform similar experiments in their Yap1-deleted/depleted cell lines to show that fate changes are mediated by Yap (these experiment may also require Taz knockdown).
Referee #3:
This study describes the role of Yap1 in the self-renewal and differentiation of mouse embryonic stem (ES) cells. Authors of this study used 3 feeder-free ES cell lines and observed increased expression of Yap1, reduction in the phosphorylation of Yap1, and nuclear accumulation of Yap1 during the differentiation of these cells after LIF withdrawal. Knockdown of the gene encoding Yap1 did not significantly affect the self-renewal and gene expression profiles of ES cells. Cells lacking Yap1 showed defects in their differentiation while cells with Yap1 overexpression underwent differentiation. Alteration of subcellular localization of Yap1 by inhibiting E-cadherin-mediated cell-cell adhesion and alteration of cell density also affected the differentiation of ES cells. Based on these results, the authors concluded that Yap1 was dispensable for the self-renewal but was required for the proper differentiation of ES cells. Interestingly, these observations are inconsistent with those of previous studies by Lian et al (2010) and Tamm et al (2011) that reported, Yap1-Tead activity was required for the self-renewal of ES cells. Although the results of the present study are of high quality and are convincing, the authors only examined Yap1. If the authors' conclusion is correct, one would expect that Tead activity is also dispensable for the self-renewal of ES cells. Addition of this information would further strengthen the authors' conclusion and would clarify whether functions of Yap were mediated by Tead in this context.
Major comment:
The data presented in this study showed that Yap1 was dispensable for the self-renewal but was required for the proper differentiation of ES cells. These results are inconsistent with those reported in studies by Lian et al (2010) and Tamm et al (2011), therefore, one should interpret these results with caution. Previous studies manipulated both Yap1 and Tead and obtained consistent results, thus, it is important to examine whether manipulation of Tead would also provide the same results as those obtained in the present study. I think that analyses of several key markers for the ES cells that are knocked down and/or overexpressed with active/inactive forms of Tead should be sufficient for this purpose.
Minor comments: 1. Throughout the manuscript, the authors considered that ICM and ES are equivalent, and therefore, that Yap performs similar roles in these cells. However, this is incorrect because ES cells are derived from the epiblast (a derivative of ICM) of hatched blastocysts and not from the ICM of early blastocysts. The role of Hippo signal/Yap1 during morula to early blastocyst stages is to specify the TE/ICM fates of the cells. However, roles of the Hippo signal/Yap1 in the epiblast are unknown. To date, no study has described the distribution of Yap in the epiblast of hatched blastocysts. Moreover, presence of Yap in the nuclei of epiblast cells cannot be ruled out.
2. Figure 2E -G. Please include the duration of culturing ES cells under differentiation conditions to obtain dES cells shown in these panels.
3. Figure 4E . The graph shows higher luciferase activity at high density. However, in the main manuscript, the result indicates reduced transcriptional activity at high density. Please recheck the accuracy of the data presented at both the instances. 
RESPONSE TO REVIEWERS Overall Response:
We appreciate all three reviewers for their critical and constructive comments on our manuscript.
Common concerns addressed by the reviewers are inner cell mass (ICM) centered interpretation of our data as well as omission of investigating the possibility of involvement of other Hippo signaling pathway components such as Taz and Tead family proteins which may compensate Yap1 functions in Yap1 depleted embryonic stem (ES) cells. In order to address reviewers' comments, we performed additional experiments including generation of other Yap1 CRISPR-Cas9 mediated knock out (KO) cell lines with CJ7 and E14 ES cells, double knockdown (KD) of Yap1 and Taz, and triple KD of Tead 1/3/4 to examine whether deletions of these genes affect self-renewal of ES cells. We also substantially revised our main text to focus on ES cell biology and clarify methods to help the readers' understanding.

Referee #1:
This MS is essentially claiming the opposite of a 5-years old paper, Lian et al., Genes and Development 2010. In that Genes and Development paper YAP was promoting ESC self-renewal and inhibiting differentiation. I was thus initially puzzled when I saw this MS, but after reconsideration of the literature and comparison with the present work, I have to say that the results of this MS are sound, indicating, admittedly quite convincingly, that YAP is in fact irrelevant for mouse ESC self renewal and instead instrumental for their differentiation. To start, some statements from the abstract should be removed: 1-1a) "whereas it is sequestered and inactive in the cytoplasm of the inner cell mass (ICM)" this is an overstatement; I am not sure this is functionally proven.
Response: Multiple papers suggested cytoplasmic localization of Yap1 in the ICM of pre-implanted embryos [2-5]. However, as commented by the reviewer, the functions of Yap1 in ICM have not been well understood. We have modified the main text to address only well-established roles of Yap1
in early embryo development.
1-1b)
Response: Since we now mainly focus on ES cells rather than ICM, we have removed this sentence as suggested.
There is an excessive emphasis on the supposed role of YAP in the trophoblast layer. Actually, YAP inactivation upregulates other differentiation markers, such as mesoderm and endoderm markers. Cdx2 is certainly a trophoblast marker but together with GATA6 it may well indicate endoderm regionalization/patterning. Again, please note that what matters here is YAP being required for differentiation not the fact that this recapitulates or not a corresponding role of YAP in the mouse gastrula, where, in fact, the role of YAP or YAP/TAZ is largely unknown as far as I can tell. In essence, the author should stick to their data and tone down any blastocyst-centered interpretation of their results.
Response: Again, we sincerely appreciate the reviewer's insightful comment to help us to improve our manuscript. We agree that comparing the roles of Yap1 in ES cell and ICM is not the main point of the manuscript. As indicated above, we now minimized blastocyst-centered interpretation of our data and focused on roles of Yap1 in ES cells throughout the revised manuscript.
1-2)
Strange enough, the authors are citing every bit literature (see below my comment on their Ref34, for example), but not a paper that is in fact consistent (not to say quite overlapping) with their own claim. Azzolin et al., in Cell 2014, figure 6, showed that double inactivation of YAP/TAZ has no effect of mouse ESC self-renewal (in line with what shown in this MS), at least in 2-inhibitors (2i) medium (Mek-i+GSK3-i). They also show that, in 1i medium (Mek-i alone), which is in fact a differentiation medium, loss of YAP and TAZ sustains pluripotency (again consistently with the claim of this MS). It appears to me that this 2014 Cell paper was centered on the role of YAP as Wnt inhibitor and did not emphasize this point sufficiently; moreover, Azzolen never showed what was actually going on with those cells nor what differentiation endogenous YAP was eventually promoting. In any case, the present MS does represent sufficient novelty and significantly extend over the Azzolen Cell paper.
In the present MS, the authors must find space (cutting short intro and other embryo-speculations) to discuss comprehensively the state of the art of YAP and mESCs, trying to help the reader in making sense of other reports, some consistent and other inconsistent. In sum: (Fig EV2) .
1-2c)
There is another paper that the authors should try to mention and discuss if space allows it. Beyer et al., Cell reports 2013, suggested that YAP and TAZ operate as inhibitors of mesendoderm gene expression, at least in human ESCs, suggesting differences between human and mouse ESCs.
Response: We thank the reviewer for constructive comment. We cited and discussed the suggested paper in our revised manuscript.
1-3)
The MS is not very easy to read and in some part almost impossible to follow:
Response: We changed our text as follows (comments 1-3a -1-3d ).
1-3a) dES, might be switched to differentiating-differentiated-ESCs
Response (Fig EV4A) ."
1-3d)
As shown in Figure 3B , DEGs in Yap1-KD cells compared to the control ES cells under differentiation condition confirmed that the genes were not properly up or down-regulated upon differentiation (Table EV3) . We further analyzed the activity of the Core and PRC modules, and confirmed that upon differentiation, the Core module activity was relatively higher while PRC module activity was lower in Yap1-KD cells than wild-type ES cells (Fig 3C) , indicating that KD of Yap1 delayed or impaired proper differentiation of ES cells.
Response: We have modified the sentences and they now read as "As shown in Fig 4B, (Fig 4C) ." Figure 4 . this whole figure is quite diluting the message and provides just correlative data. It is overall preliminary, requiring more experiments to complete the message they are trying to convey. Changing cell density, in turn correlated with changes in Yap1 localization, and then seeing some effects are three and not necessarily interconnected events; but there is no YAP functional link to demonstrate causality. Basically: as it is figure 4 might be deleted without any damage as the MS is on YAP (irrespectively of its regulation) and mESC differentiation and self renewal. Other suggested/required changes: 1-5) Figure 1 (YAP upregulation during diff.): figure 1 seems to me a consequence of Figure 2 . Please consider switching figure order. Moreover Fig 1 A-C Fig 1A-C) . However, we also agree with the reviewer's comment that former Fig 1 (Fig 3 in the revised version) Fig 1G. Fig 3D is for Supplementary info. Fig EV4D   1-10 ) Figure S1F GAPDH strip has severe problems, at least on my pdf.
1-4)
Response: We have deleted gene names in the heatmap (Current Fig 1G) and tested expression levels of additional genes by RT-qPCR as suggested (Fig EV1C). We added Fig 1H to show expression levels of multiple lineage specific marker genes. As shown in Figs 1G, 1H, and EV1C most of the genes significantly up-regulated upon differentiation of ES cells do not show significant changes in gene expression upon KD or KO of Yap1, indicating that unlike previous study, Yap1 deletion does not promote differentiation of ES cells.
1-8) Fig2g is shown in a strange way. Now the comparison with differentiating ES cells is actually emphasizing the few genes that are different between YAP KD/KO and ES cells, rather than the (possibly much larger) overlap between dES cells and YAP KO cells (that is instead
Response: We apologize for the confusion. We used expression data obtained from differentiating ES cells as our experimental controls. Upon differentiation of ES cells, we see many differentially expressed genes (core pluripotency factors are down-regulated while lineage markers are upregulated). However, we did not observe significant changes in these genes in Yap1-depleted cells (both KD and KO cells). The results suggest that KD or KO of Yap1 does not trigger differentiation of ES cells, which is different from the previous report claimed by Lian et. al. To make our results more clear, we have modified the figure as shown in
1-9)
Response: As suggested, we have moved Fig 3D to
Response: We apologize for the quality of the blot. There was a technical glitch when we converted illustrator files to PDF files. We have fixed the problem.
1-11)
It is imperative for all their cell line to show the effective knockout of YAP: by sequencing of the locus and western blot. Table EV1 , respectively.
Response: We have generated CRISPR-Cas9 mediated Yap1 KO clones using mouse CJ7 and E14 ES cell lines as commented (please see our response to the comment 1-2b). We also added Western blot and sequencing results in Fig EV2G-L and
1-12)
Fig1H is very hard to understand; and not even explained. Additionally, several of the conclusions seem to be based on improperly controlled experiments (based on the presented methods). Therefore, in my opinion much more insight into the role of Yap in ESC fate specification is required before this manuscript can be considered for publication. Moreover, there are several issues that need to be addressed, some of which are outlined below:
Response: We apologize for the lack of information. As commented, we have added additional explanation in the main text and now it reads as "The luciferase construct contains repeated Yap1-Tead binding motifs (8 times) in front of
2-1)
The manuscript fails to address or take into account several prior studies that address the roles of Yap1 in ESCs. Most importantly, prior work has shown that Yap1 functions redundantly with Taz in mouse preimplantation development and in human ES cells. Therefore, depletion of Yap1 in mouse ESCs may not be sufficient to observe any clear phenotypes. The study would benefit from additional analyses of Taz and Yap1/Taz depletion in ESCs. Fig 2A- 
Response: We appreciate the reviewer's helpful suggestion. As commented, Taz is homologous to Yap1 and shares similar domains. Since Taz may function redundantly with Yap1, we performed double KD of Yap1 and Taz using lentivirus-mediated shRNAs under drug selections (Blasticidin and Puromycin, respectively). Cells expressing both shRNAs survived and as shown in
2-2)
No details are given for how the experiments were performed in Figure 2 . The authors state that Yap1 is not required for the self-renewal of ES cells, but do not provide details regarding how the experiments being performed, how many passages were analyzed, or even at when the pluripotency markers were analyzed with respect to depletion. 
Response: We apologize for the lack of detailed information regarding cell culture condition. We added detailed experimental processes regarding virus infection and passaging of the cells in the
Response: We apologize to make the reviewer misunderstand the data. What we tried to convey in Fig 1G-K (formerly Fig 2G-J) was that loss of Yap1 in ES cells does not induce differentiation (please see our response to the comment 1-8). If Yap1 is required for the self-renewal of ES cells, Yap1-depleted ES cells would undergo differentiation and gene expression patterns must be similar to those of differentiated ES cells. However, as shown in Fig 1G-K, gene expression patterns of Yap1-depleted ES cells are more similar to normal ES cells than differentiating ES cells, supporting our idea that Yap1 is dispensable for self-renewal of ES cells.
2-5)
The details for how Yap1 localization and activity was measured and compared in undifferentiated and differentiating ESCs is unclear. From the methods section it appears that the differentiating ESCs were continually being passaged during the analysis of Yap1, whereas the undifferentiated were not, and therefore dissociation of the cells may be the primary reason for observing increased nuclear Yap1 activity under these conditions. A more clear description of these experiments is required, and if culturing conditions were different, then conclusions with regard to Yap1 activity cannot be drawn from these experiments.
Response: We apologize for not providing detailed information in the previous manuscript. As we added in the figure legends 3E-G, both ES cells and differentiating ES cells were passaged every two days. Normal ES cells grow as colonies while ES cells under differentiation condition lose their ability to form colonies and become flattened. We think differences in cell-cell contact ability between ES and differentiating ES cells may contribute to the localization of Yap1. As shown in Figs 3E-G and EV3B-D, we observed that Yap1 translocates into the nucleus upon differentiation.
2-6)
How was Yap1 overexpression achieved? No details are given. For example, were these lines generated with viral transduction? Are they stably selected? Is the expression constitutive? Were the control cells generated in parallel, and similarly selected? These variables could have a huge influence on the cellular state and must be properly controlled. Additionally, the text states that overexpressed Yap1 mainly resides in the nucleus, but this does not appear to be different that the endogenous Yap shown in the control in Figure 3D . Rather, Yap just appears to be at higher levels. (Fig EV4D and E) ."
2-7)
Based on the images in 1F, 1G and 3D and -it appears that Yap1 in abundantly localized in the nucleus of undifferentiated ES cells. The one field showing a possible increase in nuclear Yap1 levels in differentiated ES cells is unconvincing on its own -and all the conclusions regarding Yap1 localization would greatly benefit from quantitation and biochemical nuclear/cytoplasmic fractionation examined by immunoblotting.
Response: In response to the reviewer's comment, we quantified Yap1 localization with several different images and added new data in Fig EV3B-D.
2-8)
A control for Yap1 IF signal should be included in the study, particularly given that the authors have in hand a Yap1 deleted cell line. Fig EV3A. Figure 4A are not clear. To me, nuclear Yap1 levels look similar between the two conditions. Better images and quantitation would help make this conclusion more convincing.
Response: We added IF data with Yap1-KO ES cells to confirm the specificity of the Yap1 antibody in
2-9) Differences in Yap1 localization in
Response: Please see our response to the point 2-10.
2-10)
All the experiments related to cell density or E-cadherin depletion are vastly overstated, as the authors do not provide any evidence that the effects following changes in density or the loss of Ecadherin are mediated by Yap1. To draw any meaningful conclusions, the authors should perform similar experiments in their Yap1deleted/depleted cell lines to show that fate changes are mediated by Yap (these experiment may also require Taz knockdown).
Response to 2-9 and 10: Please also see our response to the comment 1-4. We agree with the reviewer's comment that our data related to the cell density or E-cadherin depletion may dilute the main claim of our manuscript. Therefore, we deleted the data and description related to the former Fig 4 from our revised manuscript.
Referee #3:
This study describes the role of Yap1 in the self-renewal and differentiation of mouse embryonic stem (ES) cells. Authors of this study used 3 feeder-free ES cell lines and observed increased expression of Yap1, reduction in the phosphorylation of Yap1, and nuclear accumulation of Yap1 during the differentiation of these cells after LIF withdrawal. Knockdown of the gene encoding Yap1 did not significantly affect the self-renewal and gene expression profiles of ES cells. Cells lacking Yap1 showed defects in their differentiation while cells with Yap1 overexpression underwent differentiation. Alteration of subcellular localization of Yap1 by inhibiting E-cadherinmediated cell-cell adhesion and alteration of cell density also affected the differentiation of ES cells. Based on these results, the authors concluded that Yap1 was dispensable for the self-renewal but was required for the proper differentiation of ES cells. Interestingly, these observations are inconsistent with those ofprevious studies by Lian et al (2010) and Tamm et al (2011) that reported, Yap1-Tead activity was required for the self-renewal of ES cells. Although the results of the present study are of high quality and are convincing, the authors only examined Yap1. If the authors' conclusion is correct, one would expect that Tead activity is also dispensable for the self-renewal of ES cells. Addition of this information would further strengthen the authors' conclusion and would clarify whether functions of Yap were mediated by Tead in this context. (Fig 2E-I ).
Major comment:
3-1)
The data presented in this study showed that Yap1 was dispensable for the self-renewal but was required for the proper differentiation of ES cells. These results are inconsistent with those reported in studies by Lian et al (2010) Figure 2E -G. Please include the duration of culturing ES cells under differentiation conditions to obtain dES cells shown in these panels. Figure 4E . The graph shows higher luciferase activity at high density. However, in the main manuscript, the result indicates reduced transcriptional activity at high density. Please recheck the accuracy of the data presented at both the instances. Thank you for the submission of your revised manuscript to our offices. We have now received the enclosed reports from the referees that were asked to assess it. While referees 1 and 3 are, in principle, now supportive of its publication, referee 2 feels that some additional work is needed to make the study fully conclusive. Since all referees agree on the potential interest of this paper, I would thus like to give you the opportunity to revise the study a second time to address the remaining concerns of reviewer 2 and the minor issue raised by referee 3.
3-3)
Response: We thank the reviewer for the comment. To clarify the experimental processes for current Fig 3E-G, we added a detailed description in the Material and Methods section (Cell culture). It reads "To differentiate ES cells, cells were washed three times with the media without LIF and then incubated for 4 days while passaging every 2 days."
3-4)
This is an interesting and overall convincing paper and the authors have done a good job in revising the MS.
The revised manuscript by Chung et al presents data arguing that Yap is not required for the maintenance of mESCs, but rather that Yap plays a critical role in mESC differentiation. The revised manuscript is stronger and written more clearly than the initial submission. However, there are a few additional comments I have that need to be addressed before potential publication.
Major comments:
-The data shown for how Tead knockdown affects mESCs is incomplete and needs to be better addressed. The primary Tead family member implicated in mESCs is Tead2 (see Tamm et al, 2011). In fact, Tamm et al state that loss of Tead2 function promotes mESCs differentiation. I think in order to make any conclusions about the Teads, Tead2 function has to be examined. Moreover, based on the image shown in Figure 2H , Tead4 knockdown is poor, making it hard for conclusions to be made about this family member.
- Figure 1b should show the reduction of Yap mRNA expression in the same samples by qPCR.
Although it is not stated I am assuming the protein lysate shown in 1c is from a different sample.
Minor comments:
-It is unclear why the authors choose to only show the correlation between Yap-kd1 vs control in Figure 1K , but not the correlation with the Yap-KO data. Since the authors have the data in hand, I think that is important to also show the correlation of Yap-KO1 and Yap-KO2, at least as supplementary material.
-The rebuttal comments state: "We also examined the Yap1 KD and KO ES cells at earlier time points as well as later time points (more than a month of passaging), but we did not observe any significant differentiation morphology." > This statement needs to be included in the manuscript. Moreover, analysis of the Yap-KO ES cells after one month for self-renewal markers should be included, as this would strengthen the conclusion that Yap is not required for mESC maintenance.
-The type of mESCs used for the Yap/Taz double knockdown and Tead knockdown experiments should be stated somewhere. Are these J1 cells? Also, details into how these cells were generated should be included in the methods section -selection conditions, passage number, etc.
-The Figure legend in Figure 1A (and other Figures) should mention the culture time in addition to the number of passages.
-Several statements throughout the manuscript should be modified. Specifically, the following:
* "Although importance of Yap1 in early cell fate decision has been well established, in particular in trophectoderm differentiation, its role in inner cell mass or embryonic stem (ES) cells remains elusive." > The authors are not studying the ICM or trophectoderm, so this sentence should be simplified to only highlight the work in ES cells. Referee #3:
I am satisfied with the revision. This is a high quality paper with novel and important information. I think that the paper is suitable for publication in EMBO Reports after incorporating one minor comment described below.
Minor comment:
In the middle of page 10, authors discussed as "the Hippo pathway is at least dispensable for selfrenewal of mouse ES cells". This sentence is misleading, because inactivation of the Hippo pathway causes nuclear localization of Yap, which should promote differentiation of ES cells. Therefore, the results suggest that active Hippo signaling is required for self-renewal of mouse ES cells. I think that it is more appropriate to rephrase this sentence, for example, as "Yap1/Taz/Tead are at least dispensable for self-renewal of mouse ES cells", or "the transcriptional effectors of the Hippo pathway are at least dispensable for self-renewal of mouse ES cells". 
Referee #1:
Referee #2:
Major comments: 2-1) The data shown for how Tead knockdown affects mESCs is incomplete and needs to be better addressed. The primary Tead family member implicated in mESCs is Tead2 (see Tamm et al, 2011).
In fact, Tamm et al state that loss of Tead2 function promotes mESCs differentiation. I think in order to make any conclusions about the Teads, Tead2 function has to be examined. Moreover, based on the image shown in Figure 2H , Tead4 knockdown is poor, making it hard for conclusions to be made about this family member. (Fig EV4E-G) .
Although we believe that the KD of Tead4 in Figure 2H was Table EV1 ). Figure 1b should show the reduction of Yap mRNA expression in the same samples by qPCR.
2-2)
Response: As commented, we included mRNA expression levels of Yap1 upon KD (Fig 1C) using the same samples used to generate Fig 1B. Minor comments: 2-3) It is unclear why the authors choose to only show the correlation between Yap-kd1 vs control in Figure 1K , but not the correlation with the Yap-KO data. Since the authors have the data in hand, I think that is important to also show the correlation of Yap-KO1 and Yap-KO2, at least as supplementary material. 
Response
2-4)
The rebuttal comments state: "We also examined the Yap1 KD and KO ES cells at earlier time points as well as later time points (more than a month of passaging), but we did not observe any significant differentiation morphology." > This statement needs to be included in the manuscript. Moreover, analysis of the Yap-KO ES cells after one month for self-renewal markers should be included, as this would strengthen the conclusion that Yap is not required for mESC maintenance.
Response:
We appreciate the reviewer's comment. We have included new data obtained from the Yap1 KO clones cultured for more than a month (Fig EV3A-C) .
2-5)
The type of mESCs used for the Yap/Taz double knockdown and Tead knockdown experiments should be stated somewhere. Are these J1 cells? Also, details into how these cells were generated should be included in the methods section -selection conditions, passage number, etc.
Response: All experiments were done in J1 ES cells unless otherwise described. We have clearly indicated names of ES cell lines we used in the figure legends. Figure 1A (and other Figures) should mention the culture time in addition to the number of passages.
2-6) The Figure legend in
Response: All samples were collected 4 days after the infection unless otherwise mentioned. As suggested, we have added culture time in the figure legends.
2-7)
Several statements throughout the manuscript should be modified. Specifically, the following: * "Although importance of Yap1 in early cell fate decision has been well established, in particular in trophectoderm differentiation, its role in inner cell mass or embryonic stem (ES) cells remains elusive." > The authors are not studying the ICM or trophectoderm, so this sentence should be simplified to only highlight the work in ES cells. 
2-9)
"mouse ES cells grow as tightly packed colonies; considering the fact that high cell density or cell-cell contact activates Hippo signaling, and subsequent sequestration of Yap1 in the cytoplasm of various cell lines such as MDA-MB-231, HaCaT, and NIH-3T3" > Referral to the MDA-MB-231 cells in this statement is inaccurate, as these cells do not exhibit robust density-mediated regulation of Yap1.
Response:
We have removed "MDA-MB-231 cells" from the text.
2-10)
"OE of Yap1 in ES cells enhances nuclear accumulation of Yap1 accompanied by induction of various lineage-specific marker genes." > Based on the images shown it looks like there is no enhanced nuclear accumulation upon Yap expression, but rather that there is enhanced nuclear abundance. I would change this sentence accordingly.
Response: As suggested, we have changed the text and now it reads as "OE of Yap1 in ES cells enhances nuclear abundance of Yap1 accompanied by induction of various lineage-specific marker genes".
Referee #3: I am satisfied with the revision. This is a high quality paper with novel and important information. I think that the paper is suitable for publication in EMBO Reports after incorporating one minor comment described below.
Minor comment: 3-1) In the middle of page 10, authors discussed as "the Hippo pathway is at least dispensable for self-renewal of mouse ES cells". This sentence is misleading, because inactivation of the Hippo pathway causes nuclear localization of Yap, which should promote differentiation of ES cells. Therefore, the results suggest that active Hippo signaling is required for self-renewal of mouse ES cells. I think that it is more appropriate to rephrase this sentence, for example, as "Yap1/Taz/Tead are at least dispensable for self-renewal of mouse ES cells", or "the transcriptional effectors of the Hippo pathway are at least dispensable for self-renewal of mouse ES cells". I am very pleased to accept your manuscript for publication in the next available issue of EMBO reports. Thank you for your contribution to our journal.
